These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25030871)

  • 1. [Mesonephric hyperplasia in uterine cervix: report of two cases].
    Zeng Y; Wu Y; Zhu X; Zhang S; Gu P; Zhu H; Qiu W; Yi X
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):339-40. PubMed ID: 25030871
    [No Abstract]   [Full Text] [Related]  

  • 2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
    Wu HW; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined expression of p161NK4a and p27Kip1, but not p21WAF1, differentiates endocervical from endometrial adenocarcinoma.
    Abu Backer FM; Mustapha NR; Othman NH
    Anal Quant Cytol Histol; 2011 Oct; 33(5):283-8. PubMed ID: 22611756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathological study of mesonephric lesions of cervix uteri and vagina.
    Kondi-Pafitis A; Kairi E; Kontogianni KI; Dimopoulou C; Sikiotis K; Smyrniotis V
    Eur J Gynaecol Oncol; 2003; 24(2):154-6. PubMed ID: 12701967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.
    Ferry JA; Scully RE
    Am J Surg Pathol; 1990 Dec; 14(12):1100-11. PubMed ID: 2252101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
    Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
    Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammaglobin expression in gynecologic adenocarcinomas.
    Hagemann IS; Pfeifer JD; Cao D
    Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
    Tambouret R; Clement PB; Young RH
    Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
    Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
    Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.
    Nishio S; Tsuda H; Fujiyoshi N; Ota S; Ushijima K; Sasajima Y; Kasamatsu T; Kamura T; Matsubara O
    Pathol Res Pract; 2009; 205(5):331-7. PubMed ID: 19167836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Florid mesonephric hyperplasia of the cervix: a report of a case with review of the literature.
    Ayroud Y; Gelfand MM; Ferenczy A
    Int J Gynecol Pathol; 1985; 4(3):245-54. PubMed ID: 2414240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesonephric hyperplasia of the uterine cervix: a clinicopathologic study of 51 cases.
    Seidman JD; Tavassoli FA
    Int J Gynecol Pathol; 1995 Oct; 14(4):293-9. PubMed ID: 8598330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
    Kenny SL; McBride HA; Jamison J; McCluggage WG
    Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p16 in post-radiotherapy cervical biopsies.
    El-Bahrawy M
    Histopathology; 2011 Jun; 58(7):1174-6. PubMed ID: 21707719
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesonephric adenocarcinoma (endometrioid type) of endocervix with diffuse mesonephric hyperplasia involving cervical wall and myometrium: an unusual case report.
    Menon S; Kathuria K; Deodhar K; Kerkar R
    Indian J Pathol Microbiol; 2013; 56(1):51-3. PubMed ID: 23924560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
    Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
    Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki67.
    Stewart CJ; Crook ML
    Int J Gynecol Pathol; 2015 Jan; 34(1):90-100. PubMed ID: 25473758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.